(Q28168410)

2

0 references

author name string

Jennifer A Klinke

1

0 references

Ellen L Toth

4

0 references

T K Lee

5

0 references

Richard Z Lewanczuk

6

0 references

Sumit R Majumdar

Cause-specific mortality in a population-based study of diabetes

7

0 references

language of work or name

English

0 references

publication date

March 2004

0 references

published in

Clinical Therapeutics

0 references

volume

26

0 references

issue

3

0 references

page(s)

439-46

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990040-9

7 January 2021

Mortality in a large population-based cohort of patients with drug-treated diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990040-9

7 January 2021

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990040-9

7 January 2021

Diabetes and cardiovascular risk factors: the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990040-9

7 January 2021

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990040-9

7 January 2021

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990040-9

7 January 2021

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990040-9

7 January 2021

Comparison of hyperglycemia, hypertension, and hypercholesterolemia management in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990040-9

7 January 2021

Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990040-9

7 January 2021

A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990040-9

7 January 2021

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990040-9

7 January 2021

Effects of aspirin treatment on survival in non-insulin-dependent diabetic patients with coronary artery disease. Israeli Bezafibrate Infarction Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990040-9

7 January 2021

Aspirin therapy in diabetes. American Diabetes Association

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990040-9

7 January 2021

Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990040-9

7 January 2021

Aspirin use among adults with diabetes: estimates from the Third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990040-9

7 January 2021

Aspirin use and counseling about aspirin among patients with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990040-9

7 January 2021

Improving aspirin prophylaxis in a primary care diabetic population

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990040-9

7 January 2021